← Open Payments lookup

COLLEEN LIZEWSKI: Open Payments

NPI 1760804512 · NAGS HEAD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,052 in 102 payments from 19 companies in 2025. Trend: 2023 $2,007 · 2024 $2,034 · 2025 $2,052

Food & beverage: $2,052
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$313
Alkermes, Inc.11$268
Otsuka America Pharmaceutical, Inc.11$223
AstraZeneca Pharmaceuticals LP9$188
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$175
ABBVIE INC.8$167
Lilly USA, LLC6$111
Teva Pharmaceuticals USA, Inc.5$94
E.R. Squibb & Sons, L.L.C.4$92
Aimmune Therapeutics, Inc.4$77

Products named: INGREZZA, LYBALVI, CAPLYTA, REXULTI, COBENFY, AIRSUPRA, ABILIFY ASIMTUFII, ZENPEP.

Industry payments across NC — which companies pay providers there.